Follow this preprint

Effectiveness of a SARS-CoV-2 mRNA vaccine booster dose for prevention of infection, hospitalization or death in two nation-wide nursing home systems

Kevin W. McConeghy, Barbara Bardenheier, Andrew W. Huang, Elizabeth M. White, Richard A. Feifer, Carolyn Blackman, Christopher M. Santostefano, Yoojin Lee, Frank DeVone, Christopher W. Halladay, James L. Rudolph, Andrew R. Zullo, Vincent Mor, Stefan Gravenstein
doi: https://doi.org/10.1101/2022.01.25.22269843
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2022.01.25.22269843
History 
  • January 28, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Kevin W. McConeghy, Pharm.D.1,2,*,
  2. Barbara Bardenheier, M.S., Ph.D.2,
  3. Andrew W. Huang, M.S.2,
  4. Elizabeth M. White, APRN, Ph.D.2,
  5. Richard A. Feifer, MD, MPH3,
  6. Carolyn Blackman, MD3,
  7. Christopher M. Santostefano, BSN, RN2,
  8. Yoojin Lee, M.S.2,
  9. Frank DeVone, M.S.1,
  10. Christopher W. Halladay, M.S.1,
  11. James L. Rudolph, M.D.1,2,
  12. Andrew R. Zullo, Pharm.D., Ph.D.1,2,
  13. Vincent Mor, Ph.D.1,2 and
  14. Stefan Gravenstein, M.D., MPH1,2,4
  1. 1Center of Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, United States
  2. 2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  3. 3Genesis HealthCare, Kennett Square, Pennsylvania, United States
  4. 4Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States
  1. ↵*Corresponding Author:
    Kevin W. McConeghy, Pharm.D., M.S., Clinical Pharmacy Specialist, Providence VA Medical Center, Ph.D. Student, Dept. of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI, (401) 273-7100x16457, Kevin_mcconeghy{at}brown.edu, Alternate:
    kevin.mcconeghy{at}va.gov, Twitter:
    @KevFromRI
Back to top
Posted January 28, 2022.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Effectiveness of a SARS-CoV-2 mRNA vaccine booster dose for prevention of infection, hospitalization or death in two nation-wide nursing home systems
Kevin W. McConeghy, Barbara Bardenheier, Andrew W. Huang, Elizabeth M. White, Richard A. Feifer, Carolyn Blackman, Christopher M. Santostefano, Yoojin Lee, Frank DeVone, Christopher W. Halladay, James L. Rudolph, Andrew R. Zullo, Vincent Mor, Stefan Gravenstein
medRxiv 2022.01.25.22269843; doi: https://doi.org/10.1101/2022.01.25.22269843
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

1

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.